PU-WS13 hydrobromide NEW
Price | $36 | $79 | $97 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-01 |
Product Details
Product Name: PU-WS13 hydrobromide | Purity: 98% |
Supply Ability: 10g | Release date: 2024/11/01 |
Product Introduction
Bioactivity
名称 | PU-WS13 hydrobromide |
描述 | PU-WS13 hydrobromide is a GRP94 inhibitor with anti-inflammatory activity and inhibits the proliferation of M2-like macrophages in mouse TNBC tumors. |
存储条件 | Shipping with blue ice. |
溶解度 | DMSO : 50 mg/mL (101.57 mM), Sonication is recommended. |
关键字 | 1454619-14-7 | PU-WS13 Hydrobromide | 1454619-14-7 Free base |
相关产品 | Vincamine | Monomethyl fumarate | Questiomycin A | CRTh2 antagonist 2 | Fezagepras sodium | Benzyl nicotinate | 1-methoxycyclopropanecarboxylic acid | TUG-1375 | CAY10595 | Timapiprant |
相关库 | 经典已知活性库 | 膜蛋白靶向化合物库 | 抑制剂库 | 抗衰老化合物库 | 已知活性化合物库 | GPCR靶点分子库 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$142.00/2mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$2500.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-22 | |
$2100.00/10ton |
VIP1Y
|
Yujiang Chemical (Shandong) Co.,Ltd.
|
2024-10-24 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hills
INQUIRY